Axe Compute Inc. $AGPU

What the company doesAI summary of filing

Axe Compute Inc. operates two business segments. Its primary focus is Compute Services and Treasury Management, through which it provides enterprises and AI developers access to GPU compute capacity through a distributed network of over 435,000 GPUs globally, typically delivering capacity within 48 hours without requiring customers to own physical hardware; the company generates revenue primarily through reserved GPU capacity contracts on a per-GPU-per-hour basis and also pursues a digital asset treasury strategy focused on acquiring and holding Aethir tokens (ATH), earning yield through staking and other activities. The company's secondary segment is Drug Discovery Services, its legacy business, which uses AI and a proprietary biobank of over 150,000 tumor samples to provide drug-response predictions and develops 3D tumor-specific culture models for oncology drug discovery; in February 2026, the company announced it is exploring strategic alternatives for this business but has not committed to a specific course of action. The company is revenue-generating in its compute services business and holds digital assets through its treasury strategy. [10-K 2026-03-31]

Segments: Compute Services, Treasury Management, Drug Discovery Services (Legacy Business)